)
)
Barinthus Biotherapeutics plc Investor Relations Material
Latest events
Status Update
Barinthus Biotherapeutics plc
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Barinthus Biotherapeutics plc
Access all reports
Barinthus Biotherapeutics plc is a biotechnology company focused on the development of novel immunotherapies for infectious diseases and cancer. The company specializes in T-cell activating therapeutics and next-generation vaccine platforms designed to enhance immune response. The company is headquartered in London, United Kingdom, and its shares are listed on the NASDAQ.
Key slides for Barinthus Biotherapeutics plc
Corporate Presentation
Barinthus Biotherapeutics plc
Corporate Presentation
Barinthus Biotherapeutics plc
Latest articles
)
Robert G. Hagstrom: Darwinian Investing and Multidisciplinary Wisdom
Robert G. Hagstrom, author of The Warren Buffett Way, explores how interdisciplinary thinking shapes his investing, from Adler's reading to Darwinian markets.
7 Feb 2025
)
Quartr Brings Stories Behind the Numbers to Light
Quartr simplifies access to IR material and puts qualitative insights and company narratives front and center.
3 Feb 2025
)
The Evolution of the IRO Role: Staying Informed and Strategic With Quartr Pro
Staying informed is critical for IROs. Quartr Pro simplifies gathering market insights and narrative positioning with unprecedented speed and precision.
3 Feb 2025
Ticker symbol
BRNS
Country
🇺🇸 United States